Fabhalta Capsules Specified Drug-use Survey

Clinical trial NCT07156149 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07156149
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

C3 Glomerulopathy

Start date: 2025-09-17
Primary completion: 2028-06-30
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.